Longeveron Inc. SEC filings LGVN
Longeveron Inc. has 530 filings in SEC EDGAR's recent list, going back to Nov 6, 2017. Its latest annual report, Form ARS, was filed on May 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 10, 2026 | — |
| 424B3 | Prospectus | Apr 17, 2026 | — |
| S-1 | Registration statement | Apr 10, 2026 | — |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B4 | Prospectus | Aug 11, 2025 | — |
| S-1/A | Amended registration statement | Aug 8, 2025 | — |
| S-1 | Registration statement | Aug 4, 2025 | — |
| S-8 | Employee stock plan registration | Jun 20, 2025 | — |
| S-3 | Shelf registration | Mar 28, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| S-1 | Registration statement | Aug 6, 2024 | — |
| 424B5 | Prospectus supplement | Jul 19, 2024 | — |
| S-8 | Employee stock plan registration | Jul 10, 2024 | — |
| 424B3 | Prospectus | Jul 10, 2024 | — |
| S-1 | Registration statement | Jun 28, 2024 | — |
| 424B3 | Prospectus | May 22, 2024 | — |
| S-1/A | Amended registration statement | May 21, 2024 | — |
| S-1 | Registration statement | Apr 30, 2024 | — |
| 424B4 | Prospectus | Apr 17, 2024 | — |
| S-1/A | Amended registration statement | Apr 16, 2024 | — |
| 424B3 | Prospectus | Apr 10, 2024 | — |
| 424B4 | Prospectus | Apr 10, 2024 | — |
| FWP | Free writing prospectus | Apr 8, 2024 | — |
| S-1/A | Amended registration statement | Apr 5, 2024 | — |
| S-1/A | Amended registration statement | Apr 3, 2024 | — |
| S-1 | Registration statement | Mar 19, 2024 | — |
| S-1 | Registration statement | Jan 29, 2024 | — |
| 424B5 | Prospectus supplement | Dec 22, 2023 | — |
| 424B3 | Prospectus | Dec 6, 2023 | — |
| S-1 | Registration statement | Nov 15, 2023 | — |
| 424B5 | Prospectus supplement | Oct 13, 2023 | — |
| 424B3 | Prospectus | Aug 14, 2023 | — |
| S-1/A | Amended registration statement | Aug 11, 2023 | — |
| S-1/A | Amended registration statement | Jul 28, 2023 | — |
| S-1 | Registration statement | Jun 27, 2023 | — |
| S-8 | Employee stock plan registration | Jun 26, 2023 | — |
| S-3 | Shelf registration | Apr 5, 2022 | — |
| 424B3 | Prospectus | Dec 22, 2021 | — |
| S-1 | Registration statement | Dec 15, 2021 | — |
| S-8 | Employee stock plan registration | Feb 16, 2021 | — |
| 424B3 | Prospectus | Feb 16, 2021 | — |
| 424B4 | Prospectus | Feb 12, 2021 | — |
| S-1MEF | Registration statement | Feb 12, 2021 | — |
| S-1/A | Amended registration statement | Feb 10, 2021 | — |
| S-1/A | Amended registration statement | Feb 8, 2021 | — |
| FWP | Free writing prospectus | Feb 5, 2021 | — |
| FWP | Free writing prospectus | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 3, 2021 | — |
| S-1 | Registration statement | Jan 19, 2021 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LGVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1721484
- Former names
- LONGEVERON LLC (until Feb 10, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.